Egan-Jones Recommends Pacira Shareholders Support All Management Nominees

NEW YORK, June 5, 2026 /PRNewswire/ -- Egan-Jones recommends that shareholders of Pacira BioSciences vote FOR all three management nominees on the BLUE proxy card and AGAINST all three nominees put forward by DOMA Perpetual Capital Management LLC at the 2026 annual meeting. Egan-Jones'...